GZGuobin Zhang

Guobin Zhang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Guobin Zhang has a total of 26 co-authors. Here are the top co-authors by number of shared publications:

  • Jun Liu

    Affiliations Department of Neurosurgery, Tianjin Huanhu Hospital, Tianjin, China, Brain Trauma, Neurosurgical Critical Care Center Huanhu Hospital, Tianjin, China, Laboratory of Micro neurosurgery, Tianjin Neurosurgical Institute, Tianjin, China, Tianjin Key Laboratory of Cerebral Vascular and Neural Degenerative Diseases, Tianjin, China

    3 shared publications
  • Shusheng Zhang

    Affiliations Department of Neurosurgery, Tianjin Huanhu Hospital, Tianjin, China, Brain Trauma, Neurosurgical Critical Care Center Huanhu Hospital, Tianjin, China, Laboratory of Micro neurosurgery, Tianjin Neurosurgical Institute, Tianjin, China, Tianjin Key Laboratory of Cerebral Vascular and Neural Degenerative Diseases, Tianjin, China

    3 shared publications
  • Yueda Chen

    Department of Neurosurgery, Tianjin HuanHu Hospital, Tianjin, China

    2 shared publications
  • Zhongzhen Li

    Affiliations Department of Neurosurgery, Tianjin Huanhu Hospital, Tianjin, China, Brain Trauma, Neurosurgical Critical Care Center Huanhu Hospital, Tianjin, China, Laboratory of Micro neurosurgery, Tianjin Neurosurgical Institute, Tianjin, China, Tianjin Key Laboratory of Cerebral Vascular and Neural Degenerative Diseases, Tianjin, China

    2 shared publications
  • Ailin Li

    Department of Neurosurgery, Tianjin HuanHu Hospital, Tianjin, China

    1 shared publication
  • Biao Zhang

    Department of Clinical Laboratory, Huanhu Hospital Affiliated to Tianjin Medical University, Tianjin, China

    1 shared publication

Latest Publications

  • Open Access

    Comparative efficacy of cisternal drainage versus external ventricular drainage in severe aneurysmal subarachnoid hemorrhage

    by Mahamat Hamid Mahamat, Tuo Li, Jun Liu, Shusheng Zhang, Ye Miao, Zhongzhen Li, Yadan Li, Hua Yan, Guobin Zhang, Xiaoguang Tong

    Background: The cerebrovascular emergency known as aneurysmal subarachnoid hemorrhage (aSAH) is potentially fatal. Although external ventricular drainage (EVD) is the gold standard for monitoring intracranial pressure (ICP), cisternal drainage (CD) should be considered as a supplementary strategy due to the limited effectiveness of EVD in removing inflammatory mediators and preventing vascular damage. Objective: To compare ICP monitoring accuracy, cerebrospinal fluid (CSF) clearance, and clinical outcomes between EVD and CD in severe aSAH patients. Methods: A retrospective study enrolled 47 Hunt-Hess IV–V grade aSAH patients, divided into EVD (n = 23) and EVD + CD (n = 24) groups. Daily ICP values (days 1/3/5/7), CSF biomarkers (cell count, protein, Interleukin-6, Interleukin-8, Tumor Necrosis Factor-α, Endothelin-1, Monocyte Chemoattractant Protein-1, Vascular Cell Adhesion Molecule-1), hospitalization duration, and 6-month Glasgow Outcome Scale (GOS) were analyzed. Results: ICP values showed no significant difference between the two groups ( p > 0.05). EVD + CD group exhibited higher CSF cell count (394.68 ± 91.32 vs. 320.40 ± 75.49), protein (16.17 ± 2.27 vs. 13.74 ± 2.94 g/L), and cytokines (IL-6/IL-8, p < 0.05) on day 1, but significantly lower levels by day 7 ( p < 0.05). Vascular injury factors (ET-1/MCP-1/VCAM-1) were reduced in the EVD + CD group by day 7 ( p < 0.05). Hospitalization duration was 22.8% shorter in the EVD + CD group (27 vs. 35 days, p = 0.030); while 6-month GOS showed no difference (2.52 vs. 2.57, p = 0.148). Conclusion: Compared with EVD, CD could not only provide accurate ICP readings and trend data but also enhance inflammatory clearance, reduce hospitalization time, and mitigate vascular injury in severe aSAH, warranting further validation in larger cohorts.

  • Cisternostomy is not beneficial to reduce the occurrence of post-traumatic hydrocephalus in Traumatic Brain Injury

    by Jun Liu, Shusheng Zhang, Yueda Chen, Xiaoxiong Jia, Zhongzhen Li, Ailin Li, Guobin Zhang, Rongcai Jiang

    Background The Cisternostomy is a novel surgical concept in the treatment of Traumatic Brain Injury (TBI), which can effectively drain the bloody cerebrospinal fluid from the skull base cistern, reduce the intracranial pressure, and improve the return of bone flap, but its preventive role in post-traumatic hydrocephalus (PTH) is unknow. The purpose of this paper is to investigate whether Cisternostomy prevents the occurrence of PTH in patients with moderate and severe TBI. Methods A retrospective analysis of clinical data of 86 patients with moderate and severe TBI from May 2019 to October 2021 was carried out in the Brain Trauma Center of Tianjin Huanhu Hospital. Univariate analysis was performed to examine the gender, age, preoperative Glasgow Coma Scale (GCS) score, preoperative Rotterdam CT score, decompressive craniectomy rate, intracranial infection rate, the incidence of subdural fluid, and incidence of hydrocephalus in patients between the Cisternostomy group and the non-Cisternostomy surgery group. we also analyzed the clinical outcome indicators like GCS at discharge,6 month GOS-E and GOS-E ≥ 5 in two groups.Additionaly, the preoperative GCS score, decompressive craniectomy rate, age, and gender of patients with PTH and non hydrocephalus were compared. Further multifactorial logistic binary regression was performed to explore the risk factors for PTH. Finally, we conducted ROC curve analysis on the statistically significant results from the univariate regression analysis to predict the ability of each risk factor to cause PTH. Results The Cisternostomy group had a lower bone flap removal rate(48.39% and 72.73%, p = 0.024)., higer GCS at discharge(11.13 ± 2.42 and 8.93 ± 3.31,p = 0.000) and better 6 month GOS-E(4.55 ± 1.26 and 3.95 ± 1.18, p = 0.029)than the non-Cisternostomy group However, there was no statistical difference in the incidence of hydrocephalus between the two groups (25.81% and 30.91%, p = 0.617). Moreover, between the hydrocephalus group and no hydrocephalus group,there were no significant differences in the incidence of gender, age, intracranial infection, and subdural fluid. While there were statistical differences in peroperative GCS score, Rotterdam CT score, decompressive craniectomy rate, intracranial infection rate, and the incidence of subdural fluid in the two groups, there was no statistical difference in the percentage of cerebral cisterns open drainage between the hydrocephalus group and no hydrocephalus group (32.00% and 37.70%, p = 0.617). Multifactorial logistic binary regression analysis results revealed that the independent risk factors for PTH were intracranial infection (OR = 18.460, 95% CI: 1.864–182.847 p = 0.013) and subdural effusion (OR = 10.557, 95% CI: 2.425–35.275 p = 0.001). Further, The ROC curve analysis showed that peroperative GCS score, Rotterdam CT score and subdural effusion had good ACU(0.785,0.730,and 0.749), with high sensitivity and specificity to predict the occurrence of PTH. Conclusions Cisternostomy may decrease morbidities associated with removal of the bone flap and improve the clinical outcome, despite it cannot reduce the disability rate in TBI patients.Intracranial infection and subdural fluid were found to be the independent risk factors for PTH in patients with TBI,and the peroperative GCS score, Rotterdam CT score and subdural effusion had higher sensitivity and specificity to predict the occurrence of PTH. And more importantly, no correlation was observed between open drainage of the cerebral cisterns and the occurrence of PTH, indicating that Cisternostomy may not be beneficial in preventing the occurrence of PTH in patients with moderate and severe TBI.


  • Functional suppression of Ripk1 blocks the NF-κB signaling pathway and induces neuron autophagy after traumatic brain injury

    by Jun Liu, Zhengkun Zhu, Leibo Wang, Jixiang Du, Biao Zhang, Xuequan Feng, Guobin Zhang

    Traumatic brain injury (TBI), known as intracranial injury, has been a serious threat to human health. Evidence exists indicating that autophagy and inflammatory responses contribute to secondary brain injury after TBI. Notably, receptor-interacting protein kinase 1 (Ripk1) exerts an important role in cell autophagy. Therefore, this study aims to explore the effect of Ripk1 on neuron autophagy and apoptosis in TBI. Initially, blood samples of patients with TBI and healthy persons were collected to detect the expression of Ripk1, nuclear factor-kappa B (NF-κB), and NF-kB inhibitor α (IKBα). Then rat models with TBI were successfully established and, respectively, treated with shRNA targeting Ripk1 (sh-Ripk1), Ripk1 overexpression plasmid (oe-Ripk1), or IKKα inhibitor (BAY 11-7082). Subsequently, reverse transcription quantitative polymerase chain reaction and Western blot analysis were conducted to detect the expression of Ripk1, IKBα, NF-κB signaling pathway-, and apoptosis-related factors. Enzyme-linked immunosorbent assay was used to detect the expression of inflammatory cytokines. Compared with healthy persons, the expression of Ripk1, NF-κB and IKBα in blood of TBI patients was significantly upregulated. After silencing of Ripk1 or inhibition of the NF-κB signaling pathway, the expression of IL-1β, IL-6, TNF-α, Bax, and cleaved-caspase-3 was downregulated, and the expression of Bcl-2, ATG5, and LC3II/LC3I was upregulated. Furthermore, neuron injury and apoptosis were notably reduced and neuron autophagy increased significantly by Ripk1 downregulation or IKKα inhibitor. Ripk1 overexpression contributed to activation of NF-κB signaling pathway, whereby aggravating TBI-induced damage. Silencing Ripk1 suppresses TBI by inhibiting inflammation and promoting autophagy of neurons via inhibition of NF-κB signaling pathway.